ZA909564B - Direct fibrinogen assay - Google Patents

Direct fibrinogen assay

Info

Publication number
ZA909564B
ZA909564B ZA909564A ZA909564A ZA909564B ZA 909564 B ZA909564 B ZA 909564B ZA 909564 A ZA909564 A ZA 909564A ZA 909564 A ZA909564 A ZA 909564A ZA 909564 B ZA909564 B ZA 909564B
Authority
ZA
South Africa
Prior art keywords
direct
fibrinogen assay
fibrinogen
assay
direct fibrinogen
Prior art date
Application number
ZA909564A
Other languages
English (en)
Inventor
Julie Frances Hoffman
Frances Hoffman Julie
Janet Black Callahan
Black Callahan Janet
Charles Hermas Swope
Hermas Swope Charles
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of ZA909564B publication Critical patent/ZA909564B/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84—Systems specially adapted for particular applications
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Plasma & Fusion (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA909564A 1989-12-01 1990-11-28 Direct fibrinogen assay ZA909564B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44394889A 1989-12-01 1989-12-01

Publications (1)

Publication Number Publication Date
ZA909564B true ZA909564B (en) 1992-11-25

Family

ID=23762843

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA909564A ZA909564B (en) 1989-12-01 1990-11-28 Direct fibrinogen assay

Country Status (9)

Country Link
EP (1) EP0502103A4 (xx)
JP (1) JPH05503008A (xx)
KR (1) KR920704117A (xx)
AU (1) AU641459B2 (xx)
CA (1) CA2068221A1 (xx)
FI (1) FI922312A0 (xx)
IE (1) IE904244A1 (xx)
WO (1) WO1991008460A1 (xx)
ZA (1) ZA909564B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5708591A (en) * 1995-02-14 1998-01-13 Akzo Nobel N.V. Method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions
US6898532B1 (en) 1995-06-07 2005-05-24 Biomerieux, Inc. Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
US6321164B1 (en) 1995-06-07 2001-11-20 Akzo Nobel N.V. Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade
US6429017B1 (en) 1999-02-04 2002-08-06 Biomerieux Method for predicting the presence of haemostatic dysfunction in a patient sample
US6502040B2 (en) 1997-12-31 2002-12-31 Biomerieux, Inc. Method for presenting thrombosis and hemostasis assay data
ATE282208T1 (de) 1999-02-04 2004-11-15 Bio Merieux Inc Verfahren und vorrichtung zum vorhersagen von haemostatischer funktionsstörung in patientenproben
US7179612B2 (en) 2000-06-09 2007-02-20 Biomerieux, Inc. Method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality
CN110257475B (zh) * 2019-06-28 2023-05-02 深圳市国赛生物技术有限公司 纤维蛋白原检测试剂及其制备方法及检测试剂制品

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3432268A (en) * 1964-08-28 1969-03-11 Peter Unger Method and apparatus for testing cell suspensions
US3658480A (en) * 1970-04-13 1972-04-25 Bio Data Corp Coagulation timing apparatus, and method
US3833864A (en) * 1972-11-30 1974-09-03 R Kiess Digital direct reading colorimeter
US3861877A (en) * 1974-01-21 1975-01-21 Clinical Technology Inc Optical analysis of fluids
US3905769A (en) * 1974-02-28 1975-09-16 Bagley Wallace E Method and apparatus for measuring prothrombin time and the like
US3989382A (en) * 1975-01-22 1976-11-02 Bio-Data Corporation Platelet aggregation monitoring device
EP0059277A1 (en) * 1981-03-02 1982-09-08 J. & P. Coats, Limited Rapid quantative measurement of fibrinogen in blood plasma
AT382971B (de) * 1981-06-16 1987-05-11 Hoffmann La Roche Verfahren und vorrichtung zur messung der blutgerinnungszeit
GB8426004D0 (en) * 1984-10-15 1984-11-21 Ortho Diagnostic Systems Inc Coagulation monitoring
IT1209604B (it) * 1984-11-27 1989-08-30 Instrumentation Lab Spa Metodo ed apparecchiatura per la misura di parametri di coagulazione.

Also Published As

Publication number Publication date
CA2068221A1 (en) 1991-06-02
EP0502103A1 (en) 1992-09-09
AU6898391A (en) 1991-06-26
EP0502103A4 (en) 1993-05-05
JPH05503008A (ja) 1993-05-27
FI922312A (fi) 1992-05-21
AU641459B2 (en) 1993-09-23
KR920704117A (ko) 1992-12-19
FI922312A0 (fi) 1992-05-21
WO1991008460A1 (en) 1991-06-13
IE904244A1 (en) 1991-06-05

Similar Documents

Publication Publication Date Title
ZA902710B (en) Enzyme luminescence assay
EP0419831A3 (en) Substituted sulfonylaminoazoles
GB8910958D0 (en) Assay
GB8913474D0 (en) Assay method
ZA909564B (en) Direct fibrinogen assay
GB2239601B (en) Odontotherapeutical materials
EP0422369A3 (en) Substituted carbamoyltriazoles
EP0416363A3 (en) Modified polyarylenesulfides
GB8919411D0 (en) Assay method
GB2250026B (en) Assays using albumin-tetrazolium interaction
IL95678A0 (en) Novel alkanophenones
GB8727479D0 (en) Riboflavin-linked assay
EP0463119A4 (en) Substituted 2-aminotetralins
EP0414067A3 (en) Substituted arylsulfonyl-aminoguanidinoazine
GB8820375D0 (en) Assay
GB8621495D0 (en) Assay
GB8900732D0 (en) Agents
GB8922909D0 (en) Assay method
GB8924112D0 (en) Assay pretreatment
GB8918223D0 (en) Assay
IL95679A0 (en) Novel alkanophenones
GB8922265D0 (en) Assay methods
GB8809899D0 (en) Assay
GB8924215D0 (en) Point mutation assay
GB8713418D0 (en) Assay